THERALASE TECHNOLOGIES

theralase-technologies-logo

Theralase Technologies is a biopharmaceutical company focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients. Theralaseโ€™s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease stat... es. The Therapeutic Laser Technology division is focused on the development and commercialization of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing. The Photo Dynamic Therapy division is focused on the discovery and development of small, light-activated molecules and companion laser systems that activate them with high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.

#SimilarOrganizations #Website #More

THERALASE TECHNOLOGIES

Industry:
Biotechnology Medical Device

Founded:
1994-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.theralase.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

aeroclean-technologies-logo

Aeroclean Technologies

Aeroclean Technologies develops an interior space air purification technology company.

burzynski-research-institute-logo

Burzynski Research Institute

Burzynski Research Institute (BRI) is a biopharmaceutical company.

not_available_image

MultiCell Technologies

MultiCell Technologies is a biopharmaceutical company.

takeda-oncology-logo

Takeda Oncology

Takeda Oncology is a leading biopharmaceutical company.

Stock Details


Company's stock symbol is CVE:TLT

Official Site Inspections

http://www.theralase.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.6 K

  • Host name: 104.21.12.126
  • IP address: 104.21.12.126
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Theralase Technologies"

Theralase Technologies Inc. โ€“ Theralase Technologies

Theralase® is focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical โ€ฆSee details»

Theralase® Announces Leadership Reorganization

Nov 15, 2021 ® Technologies Inc. (โ€œTheralase®โ€ or the โ€œCompanyโ€) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development โ€ฆSee details»

Theralase Technologies - Crunchbase Company Profile โ€ฆ

Theralase Technologies is a biopharmaceutical company focused on the design, development, manufacturing, and sale of patented laser technology platforms โ€ฆSee details»

Theralase Announces Leadership Reorganization - Financial Post

Nov 15, 2021 Theralase ® Technologies Inc. Theralase ® is a clinical stage pharmaceutical company dedicated to the research and development of innovative Anti-Cancer Therapy โ€ฆSee details»

Theralase Technologies Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Theralase Technologies Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»

Theralase Technologies Company Description - Stock Analysis

4 days ago Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic โ€ฆSee details»

Theralase Technologies (TSXV: TLT) - LinkedIn

Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug ...See details»

Theralase Announces Leadership Transition - Financial Post

TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) โ€” Theralase ® Technologies Inc. (โ€œTheralase ® โ€ or the โ€œCompanyโ€) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical โ€ฆSee details»

THERALASE INC. in 41 HOLLINGER ROAD TORONTO ON M4B 3G4 โ€ฆ

Jan 3, 2025 THERALASE INC. is a Canada Non-Distributing Corporation With 50 Or Fewer Shareholders filed on July 13, 1995. The company's filing status is listed as Active and its File โ€ฆSee details»

Theralase Technologies - Craft

Theralase Technologies is a company that develops light-activated photodynamic compounds. It specializes in personalized anti-cancer and cool laser therapy. The company offers โ€ฆSee details»

Theralase Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Theralase Inc of North York, ON. Get the latest business insights from Dun & Bradstreet.See details»

Our History - Theralase Technologies Inc.

Our HistoryCompany OverviewThe Theralase® HistoryFounded in 1994, Theralase® Technologies Inc. began the commercialization of Cool Laser Therapy (โ€œCLTโ€) for the elimination of chronic knee pain and continues this โ€ฆSee details»

Theralase Announces Leadership Reorganization - GlobeNewswire

Nov 15, 2021 Dr. Madzarevic, appointed Director of Clinical Development and Quality Assurance at Theralase ® stated, โ€œIt is a pleasure to join the Theralase ® clinical research โ€ฆSee details»

Company Theralase Technologies Inc. - MarketScreener.com

Dec 31, 2003 Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound โ€ฆSee details»

2025-05-05 | Theralase Clinical Data Presented at Canadian โ€ฆ

1 day ago Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage โ€ฆSee details»

Theralase Clinical Data Presented at Canadian Bladder Cancer โ€ฆ

14 hours ago Theralase® has enrolled and treated 79 patients in Study II, who have been provided the primary Study Procedure (therapeutic dose of Theralase®'s lead small molecule โ€ฆSee details»

Corporate Presentation | Theralase Technologies Inc. โ€“ Theralase ...

Investor RelationsCorporate Presentations READ/DOWNLOAD PDF Theralase® newsletterLet's Stay in TouchSign up to our newsletter to stay informed on news and updates from Theralase โ€ฆSee details»

Investors and Media - Theralase Technologies Inc.

Theralase® TechnologiesInvestors and Media OverviewA Compelling Story, A Sound Investment 1 in 2 Canadians will be diagnosed with cancer during their lifetime*Theralase Technologies โ€ฆSee details»

Theralase Clinical Data Presented at Canadian Bladder Cancer โ€ฆ

1 day ago Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage โ€ฆSee details»

Theralase Clinical Data Presented at Canadian Bladder Cancer โ€ฆ

14 hours ago Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage โ€ฆSee details»

linkstock.net © 2022. All rights reserved